JM Financial Ltd. Share Price

Tata Chemicals falls 10% as soda ash weakness drags earnings

Tata Chemicals Ltd (

M&M Financial Services – Technical Analysis

The stock

Paytm closes near its 52-week high on friday

IT Deal Pipeline: What Could It Mean for Indian IT Stocks?

Imagine a technology company entering a quarter with its order book getting stronger, while large deals are lining up at record levels. That is the story emerging around **Coforge**. According to a JM Financial report cited by Business Standard, Coforge remains confident about growth, with management targeting sustainable **3–4% sequential constant-currency revenue growth**. The company also indicated that its large-deal pipeline is at a record level. But the bigger learning is not just about one company. When technology spending improves and large outsourcing contracts increase, the broader Indian IT-services ecosystem can potentially benefit through stronger revenue visibility, new client wins and higher deal activity. 📌 **Nifty 500 stocks to track for educational study:** • **

UPI Revenue Shift: Paytm’s Uncertain Windfall

Starting 15 October, the National Payments Corporation of India (NPCI) will impose a 0.4% merchant discount rate (MDR) on UPI person‑to‑merchant (P2M) transactions above ₹2,000, capped at ₹300. While this marks a move away from subsidies toward a contractual revenue model, the actual benefit for Paytm hinges on how MDR is shared among banks and payment players. Revenue Distribution Uncertainty: Analysts differ on !PAYTM ’s share of MDR. JM Financial estimates a 20% allocation, equating to 8 basis points, while Emkay Global projects 10 bps. Since MDR must be split across issuing and acquiring banks, Paytm’s eventual earnings remain unclear. Shrinking Eligible Pool: Although high‑value UPI transactions (>₹2,000) represent 67% of transaction value, concessions for sectors like railways, telecom, insurance, fuel, and agriculture—plus exemptions for small merchants—reduce the effective pool. JM expects only 20% of volumes to qualify, while Emkay sees 35%. Revenue Projections Diverge: Emkay forecasts ₹1,120 crore in incremental MDR revenue for Paytm by FY28, whereas JM projects just ₹473 crore. After accounting for lost UPI incentives, JM expects net incremental MDR of ₹443 crore, fully flowing into EBITDA. Operational Performance: In Q1FY27, Paytm reported ₹2,448 crore in operating revenue, with payment services contributing ₹1,384 crore. Merchant GMV grew 31% YoY to ₹7.1 trillion, boosting revenue 28% and expanding EBITDA margin from 1% to 8%. Competitive Landscape: Despite gains in market share (from 5.6% to 6.7%), Paytm lags far behind PhonePe (49.4%) and Google Pay (33.7%). To capture more large‑ticket flows, Paytm may need to offer MDR discounts to merchants, limiting upside. Still, investors remain upbeat, with the stock up 37% in 2026, trading at ~35x FY28 EV/EBITDA.

Pine Labs could be a significant beneficiary of the MDR